Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Other Operating Expenses (2022 - 2025)

Historic Other Operating Expenses for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to $256000.0.

  • PAVmed's Other Operating Expenses changed N/A to $256000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year change of. This contributed to the annual value of $17.0 million for FY2024, which is 160260.0% up from last year.
  • According to the latest figures from Q3 2025, PAVmed's Other Operating Expenses is $256000.0.
  • Over the past 5 years, PAVmed's Other Operating Expenses peaked at $7.9 million during Q4 2022, and registered a low of -$17.1 million during Q1 2022.
  • Its 4-year average for Other Operating Expenses is $1.6 million, with a median of $1.0 million in 2023.
  • In the last 5 years, PAVmed's Other Operating Expenses skyrocketed by 54270.0% in 2024 and then plummeted by 9565.94% in 2025.
  • PAVmed's Other Operating Expenses (Quarter) stood at $7.9 million in 2022, then crashed by 87.31% to $1.0 million in 2023, then plummeted by 79.7% to $203000.0 in 2024, then grew by 26.11% to $256000.0 in 2025.
  • Its Other Operating Expenses was $256000.0 in Q3 2025, compared to $261000.0 in Q2 2025 and $283000.0 in Q1 2025.